[{"address1": "20 Park Plaza", "address2": "Suite 424", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 744 4400", "website": "https://www.cervomed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CervoMed Inc., a a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in DLB and certain other major neurological disorders. It is being evaluated in a Phase 2b study in patients with DLB. The company develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Dr. John J. Alam M.D.", "age": 62, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 807803, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sylvie L. Gregoire Pharm.D.", "age": 63, "title": "Co-Founder & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 42537, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. William Robert Elder J.D.", "age": 41, "title": "CFO, General Counsel & Corporate Secretary", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 548741, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Marinus  Verwijs Ph.D.", "age": 48, "title": "Executive Vice President of Technical Operations", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Blackburn M.H.A.", "age": 60, "title": "Executive Vice President of Clinical Development", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 404940, "exercisedValue": 0, "unexercisedValue": 4087}, {"maxAge": 1, "name": "Dr. Mark A. De Rosch Ph.D.", "age": 60, "title": "Executive VP of Regulatory, Government Affairs & Program Management", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Claudia  Ordonez M.D.", "age": 58, "title": "Senior Vice President of Medical Science", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew  Winton Ph.D.", "age": 46, "title": "Chief Commercial & Business Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.08, "open": 7.1, "dayLow": 6.9701, "dayHigh": 7.16, "regularMarketPreviousClose": 7.08, "regularMarketOpen": 7.1, "regularMarketDayLow": 6.9701, "regularMarketDayHigh": 7.16, "payoutRatio": 0.0, "beta": -6.357, "forwardPE": -2.7834647, "volume": 43759, "regularMarketVolume": 43759, "averageVolume": 324704, "averageVolume10days": 83640, "averageDailyVolume10Day": 83640, "bid": 5.1, "ask": 8.96, "bidSize": 2, "askSize": 2, "marketCap": 65416724, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 16.94, "allTimeHigh": 2902500.0, "allTimeLow": 1.8, "priceToSalesTrailing12Months": 8.411597, "fiftyDayAverage": 8.657, "twoHundredDayAverage": 7.1961, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 31885558, "profitMargins": -2.90755, "floatShares": 5480108, "sharesOutstanding": 9252719, "sharesShort": 205555, "sharesShortPriorMonth": 192726, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0222, "heldPercentInsiders": 0.31399, "heldPercentInstitutions": 0.23679, "shortRatio": 1.86, "shortPercentOfFloat": 0.0321, "impliedSharesOutstanding": 9265806, "bookValue": 3.614, "priceToBook": 1.9562812, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -22611892, "trailingEps": -2.63, "forwardEps": -2.54, "lastSplitFactor": "2:3", "lastSplitDate": 1692230400, "enterpriseToRevenue": 4.1, "52WeekChange": -0.46071702, "SandP52WeekChange": 0.16625166, "quoteType": "EQUITY", "currentPrice": 7.07, "targetHighPrice": 31.0, "targetLowPrice": 11.0, "targetMeanPrice": 20.57143, "targetMedianPrice": 20.0, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 33531166, "totalCashPerShare": 3.624, "totalDebt": 0, "quickRatio": 7.733, "currentRatio": 8.204, "totalRevenue": 7776968, "revenuePerShare": 0.887, "returnOnAssets": -0.33631, "returnOnEquity": -0.54214, "grossProfits": -14381149, "freeCashflow": -14766463, "operatingCashflow": -23314562, "revenueGrowth": -0.466, "grossMargins": -1.8492, "ebitdaMargins": 0.0, "operatingMargins": -3.76411, "financialCurrency": "USD", "symbol": "CRVO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_280597237", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1761344946, "regularMarketTime": 1761336001, "shortName": "CervoMed Inc.", "longName": "CervoMed Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1211549400000, "epsTrailingTwelveMonths": -2.63, "epsForward": -2.54, "epsCurrentYear": -2.45833, "priceEpsCurrentYear": -2.8759363, "fiftyDayAverageChange": -1.5869994, "fiftyDayAverageChangePercent": -0.18331979, "twoHundredDayAverageChange": -0.12610006, "twoHundredDayAverageChangePercent": -0.01752339, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "postMarketChangePercent": 0.0, "postMarketPrice": 7.07, "postMarketChange": 0.0, "regularMarketChange": -0.00999975, "regularMarketDayRange": "6.9701 - 7.16", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 324704, "fiftyTwoWeekLowChange": 5.2700005, "fiftyTwoWeekLowChangePercent": 2.927778, "fiftyTwoWeekRange": "1.8 - 16.94", "fiftyTwoWeekHighChange": -9.870001, "fiftyTwoWeekHighChangePercent": -0.58264464, "fiftyTwoWeekChangePercent": -46.0717, "dividendDate": 1544745600, "earningsTimestampStart": 1762518600, "earningsTimestampEnd": 1762518600, "isEarningsDateEstimate": true, "regularMarketChangePercent": -0.141239, "regularMarketPrice": 7.07, "displayName": "CervoMed", "trailingPegRatio": null, "__fetch_time": "2025-10-25"}]